Study on VR-Directed Therapy for Pain Management in IBD Patients
A study is underway to evaluate the feasibility and acceptability of VR-directed brain-gut behavioral therapy for hospitalized IBD patients.
Phase III
Gastroenterology / Inflammatory Bowel Disease
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing study on VR-directed therapy for IBD patients represents a potential shift in pain management strategies, emphasizing non-pharmacological approaches. Successful outcomes could redefine treatment paradigms and create competitive pressures for pharma companies to innovate complementary therapies.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor enrollment numbers and completion rates of the VR-directed BGBT program, as well as patient feedback on acceptability.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.